Company intelligence / Profile preview

Avixgen

Seoul, Seoul, South Koreaprnewswire.com ↗

Ownership: Private
Employees: ~3
Development stage: Phase 2

Overview

Avixgen develops small molecule and non-steroidal drugs targeting ophthalmic and inflammatory diseases. Its lead program for dry eye disease has completed Phase I trials in Korea with plans for simultaneous Phase II trials in Korea and the US. The company also has programs for age-related macular degeneration—both as injections and eye drops—with demonstrated long-lasting efficacy in preclinical models. Additional pipeline assets target atopic dermatitis with a novel non-steroidal mechanism, as well as infectious diseases such as HIV/AIDS using rhodanine derivatives.

Therapeutic areas: DermatologyOphthalmologyInfectious Diseases
Modalities: Small moleculesNon-steroidal agentsEye drops and injections (formulation modalities)
Industry: Biotech

Drug pipeline

7 assets

AVI-3307

Preclinical

6 more assets in the full pipeline.

Request access →

Partnerships

Collaboration with parent company DxVxparticipation in national drug development projectsclinical trial collaborations with major Korean hospitals including Seoul National University Bundang HospitalSeoul National University HospitalCatholic University St. Mary HospitalHyundai Asan Medical CenterSinchon Severance HospitalH Plus Yangi Hospital

Beyond the preview

Go deeper on Avixgen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avixgen.

Explore the full profile